Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Michigan Medical Genetics Laboratories, |
RCV000210958 | SCV000195949 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-11-03 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000210958 | SCV000488647 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-05-12 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000501701 | SCV000591701 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000210958 | SCV000743245 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-05-04 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000210958 | SCV000744388 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000210958 | SCV001138972 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002222176 | SCV002025981 | likely benign | Hereditary breast ovarian cancer syndrome | 2021-11-16 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000501701 | SCV002550258 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV001689741 | SCV001906385 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001689741 | SCV001952860 | likely benign | not provided | no assertion criteria provided | clinical testing |